Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux.
Garcia
Isabel
I
Department of Otolaryngology, Hospital Universitario Ramón y Cajal, Madrid.
Krishna
Priya
P
Rosen
Clark A
CA
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005764:Gastroesophageal Reflux / Q000150:complications*; D006685:Hoarseness; D006801:Humans; D007642:Keratosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D007818:Laryngeal Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D007820:Laryngeal Mucosa / Q000473:pathology*; D007828:Laryngoscopy; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors; D017494:Proton Pumps / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000150:complications; D013454:Sulfoxides / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D017494:Proton Pumps; D013454:Sulfoxides; D011899:Ranitidine; D000077402:Pantoprazole; D009853:Omeprazole